Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, comments on the Chancellor's Autumn Budget: ...

Semaglutide (the essential ingredient in Rybelsus, Ozempic and Wegovy) is currently in the headlines after the disappointing ...

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or ...

Get in touch today to find out more about Singing for the Brain and how you can deliver your own group as an Alzheimer’s Society Delivery Partner.

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

Our extensive list of publications below is grouped within categories to make it easier to find the right information. You can see the whole list of booklets and factsheets if you click the ‘Expand ...

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed. Full results ...

Alzheimer’s Society has commented on Carers UK’s ‘State of Caring 2021’ report. The report is a snapshot of unpaid care in the UK this year. Alzheimer’s Society estimates there are 700,000 unpaid ...

Amyloid is a protein that is found in our brains and bodies, but in Alzheimer’s disease, amyloid sticks together and forms different sized clumps that later become plaques in the brain. Amyloid is ...

Rhymes and engaging illustrations to help start conversations and relieve anxieties about someone close who may have dementia. Aimed at four- to 10-year-olds. My Grandma Has Dementia, by Alex ...

In the middle stage of dementia, symptoms become more noticeable and the person will need more support in managing daily life. This stage of dementia is often the longest. On average it lasts about ...

Research project: Understanding the molecular basis of Amyloid beta peptide interaction by neprilysin in Alzheimer’s disease.